# Antimicrobial Susceptibility Patterns and Biofilm Formation of Staphylococcus aureus Strains Isolated from Pediatric Patients with Atopic Dermatitis

**Authors:** Carolina Romo-González, Alejandra Aquino-Andrade, Abril Pérez-Carranza, Diana Chaparro-Camacho, Andrea Becerril-Osnaya, Maria Teresa García-Romero

PMC · DOI: 10.3390/microorganisms14020311 · Microorganisms · 2026-01-29

## TL;DR

This study examines how Staphylococcus aureus strains from children with atopic dermatitis form biofilms and resist antibiotics, linking these factors to disease severity and treatment outcomes.

## Contribution

The study reveals a novel association between S. aureus biofilm formation and treatment failure in pediatric atopic dermatitis.

## Key findings

- 60.2% of S. aureus isolates exhibited moderate-to-strong biofilm production.
- Biofilm production was significantly associated with severe AD, lack of clinical improvement, and persistent disease.
- Isolates from patients using dilute bleach baths showed higher resistance to ciprofloxacin and MLSB resistance patterns.

## Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by barrier dysfunction and susceptibility to Staphylococcus aureus colonization. Biofilm formation modifies antibiotic resistance and the host immune response. This longitudinal study analyzed antimicrobial susceptibility and biofilm formation in 136 S. aureus isolates obtained over 18 months from lesional, nonlesional, and nasal samples of 26 pediatric patients with moderate-to-severe AD. Antimicrobial susceptibility testing was determined by the disk diffusion method, and biofilm production was quantified using a crystal violet microtiter assay. Clinical parameters, including disease severity, treatment response, and the administration of dilute bleach baths, were evaluated in relation to bacterial characteristics. Overall, 60.2% of isolates exhibited moderate-to-strong biofilm production, significantly associated with severe AD at baseline (p = 0.01), lack of clinical improvement (p = 0.04), and persistent moderate-to-severe disease (p = 0.01). Resistance rates for penicillin, gentamicin, clindamycin, and erythromycin exceeded 15%. Isolates from patients using dilute bleach baths showed greater resistance to ciprofloxacin (p < 0.0001) and exhibited constitutive or inducible macrolide–lincosamide–streptogramin B (MLSB) resistance, with ermA detected in 80% of inducible cases. In conclusion, S. aureus biofilm formation is linked to disease severity and treatment failure in pediatric AD, underscoring the importance of culture-guided, targeted therapeutic strategies.

## Linked entities

- **Chemicals:** penicillin (PubChem CID 2349), gentamicin (PubChem CID 3467), clindamycin (PubChem CID 446598), erythromycin (PubChem CID 12560), ciprofloxacin (PubChem CID 2764), doxorubicin (PubChem CID 31703)
- **Diseases:** atopic dermatitis (MONDO:0004980)
- **Species:** Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Genes:** msrA [NCBI Gene 17374484], ermA [NCBI Gene 13913675], MSRA (methionine sulfoxide reductase A) [NCBI Gene 4482] {aka PMSR}, ermC [NCBI Gene 13913672]
- **Diseases:** pruritus (MESH:D011537), staphylococcal (MESH:D011023), MLSB (MESH:D006509), skin disease (MESH:D012871), injury to (MESH:D014947), inflammation (MESH:D007249), MRSA (MESH:D013203), AD (MESH:D003876), infection (MESH:D007239), sweat duct occlusion (MESH:D001157), catheter-associated infections (MESH:D055499)
- **Chemicals:** methicillin (MESH:D008712), erythromycin (MESH:D004917), fusidic acid (MESH:D005672), GM (MESH:D005839), levofloxacin (MESH:D064704), E (MESH:D004540), water (MESH:D014867), CC (MESH:D002981), agar (MESH:D000362), CIP (MESH:D002939), P (MESH:D010758), cefoxitin (MESH:D002440), NaCl (MESH:D012965), glucose (MESH:D005947), beta-lactam (MESH:D047090), alcohol (MESH:D000438), saccharose (MESH:D013395), trimethoprim-sulfamethoxazole (MESH:D015662), agarose (MESH:D012685), mannitol (MESH:D008353), steroids (MESH:D013256), Sodium hypochlorite (MESH:D012973), LIN (MESH:D000069349), acetone (MESH:D000096), penicillin (MESH:D010406), TE (MESH:D013752), MSB (-), S (MESH:D013455), crystal violet (MESH:D005840)
- **Species:** Candida albicans (species) [taxon 5476], Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12943069/full.md

## References

61 references — full list in the complete paper: https://tomesphere.com/paper/PMC12943069/full.md

---
Source: https://tomesphere.com/paper/PMC12943069